Literature DB >> 9589514

The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia.

D F Horrobin1.   

Abstract

The neurodevelopmental hypothesis of schizophrenia is becoming an important feature of research in the field. However, its major drawback is that it lacks any biochemical basis which might draw the diverse observations together. It is suggested that the membrane phospholipid hypothesis can provide such a biochemical basis and that the neurodevelopmental phospholipid concept offers a powerful paradigm to guide future research.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9589514     DOI: 10.1016/s0920-9964(97)00151-5

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  59 in total

Review 1.  Apolipoprotein D.

Authors:  Eric Rassart; Frederik Desmarais; Ouafa Najyb; Karl-F Bergeron; Catherine Mounier
Journal:  Gene       Date:  2020-06-15       Impact factor: 3.688

2.  Monitoring the oxidation of docosahexaenoic acid in lipids.

Authors:  Ann-Marie Lyberg; Ezio Fasoli; Patrick Adlercreutz
Journal:  Lipids       Date:  2005-09       Impact factor: 1.880

Review 3.  Inflammation and the two-hit hypothesis of schizophrenia.

Authors:  Keith A Feigenson; Alex W Kusnecov; Steven M Silverstein
Journal:  Neurosci Biobehav Rev       Date:  2013-11-15       Impact factor: 8.989

4.  Can anti-inflammatory medications improve symptoms and reduce mortality in schizophrenia?

Authors:  Maju Mathew Koola; Jeffrey K Raines; Robert G Hamilton; Robert P McMahon
Journal:  Curr Psychiatr       Date:  2016-04-25

5.  Biomarkers and clinical staging in psychiatry.

Authors:  Patrick McGorry; Matcheri Keshavan; Sherilyn Goldstone; Paul Amminger; Kelly Allott; Michael Berk; Suzie Lavoie; Christos Pantelis; Alison Yung; Stephen Wood; Ian Hickie
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

6.  Deficit in prepulse inhibition in mice caused by dietary n-3 fatty acid deficiency.

Authors:  Irina Fedorova; Anita R Alvheim; Nahed Hussein; Norman Salem
Journal:  Behav Neurosci       Date:  2009-12       Impact factor: 1.912

Review 7.  Clinical potential of omega-3 fatty acids in the treatment of schizophrenia.

Authors:  Robin Emsley; Piet Oosthuizen; Susan J van Rensburg
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

8.  Dietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33,000 women from the general population.

Authors:  Maria Hedelin; Marie Löf; Marita Olsson; Tommy Lewander; Björn Nilsson; Christina M Hultman; Elisabete Weiderpass
Journal:  BMC Psychiatry       Date:  2010-05-26       Impact factor: 3.630

9.  Association between polymorphisms of arachidonate 12-lipoxygenase (ALOX12) and schizophrenia in a Korean population.

Authors:  Tae Kim; Hak-Jae Kim; Jin Kyung Park; Jong Woo Kim; Joo-Ho Chung
Journal:  Behav Brain Funct       Date:  2010-07-14       Impact factor: 3.759

10.  Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis.

Authors:  S Smesny; B Milleit; U-C Hipler; C Milleit; M R Schäfer; C M Klier; M Holub; I Holzer; G E Berger; M Otto; I Nenadic; M Berk; P D McGorry; H Sauer; G P Amminger
Journal:  Mol Psychiatry       Date:  2013-03-12       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.